Table 2.
Type I endometrial cancers | Type II endometrial cancers | |
---|---|---|
Hormonal impact | Estrogen dependent | Estrogen independent |
Histology | Endometrioid adenocarcinomas | Clear-cell, serous, uterine carcinosarcomas |
Patient population | Younger, obese, perimenopausal | Older, thin, postmenopausal |
Distribution | 85% | 15% |
Prognosis | Better differentiated | More aggressive, proportionally higher mortality |
Genetic mutations | Kras, PTEN, MLH1 | p53, erbB2 |